VICEM Cement Trading JSC (HNX:TMX)
11,000
+400 (3.77%)
At close: Jul 28, 2025
Intercept Pharmaceuticals Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 23,296 | 30,685 | 55,120 | 31,608 | 30,000 | 30,088 | Upgrade |
Short-Term Investments | 46,399 | 40,003 | 60,473 | 90,000 | 85,000 | 90,000 | Upgrade |
Cash & Short-Term Investments | 69,695 | 70,688 | 115,593 | 121,608 | 115,000 | 120,088 | Upgrade |
Cash Growth | -39.71% | -38.85% | -4.95% | 5.75% | -4.24% | -7.30% | Upgrade |
Accounts Receivable | 7,977 | 4,657 | 12,108 | 1,102 | 1,110 | 6,701 | Upgrade |
Other Receivables | 7,560 | 2,654 | 3,404 | 10,573 | 11,966 | 13,642 | Upgrade |
Receivables | 15,537 | 7,311 | 15,512 | 11,675 | 13,076 | 20,342 | Upgrade |
Inventory | 4,335 | 3,075 | 2,627 | 2,358 | 2,266 | 4,566 | Upgrade |
Prepaid Expenses | - | - | 49.14 | - | - | - | Upgrade |
Other Current Assets | 51,906 | 52,777 | 3,013 | 4,072 | 1,904 | 4,346 | Upgrade |
Total Current Assets | 141,473 | 133,852 | 136,794 | 139,713 | 132,246 | 149,343 | Upgrade |
Property, Plant & Equipment | 2,539 | 2,735 | 3,126 | 1,783 | 2,170 | 2,587 | Upgrade |
Total Assets | 144,012 | 136,587 | 139,920 | 141,496 | 134,416 | 151,930 | Upgrade |
Accounts Payable | 3,131 | 26,304 | 29,962 | 31,623 | 22,839 | 34,499 | Upgrade |
Accrued Expenses | 44,353 | 8,549 | 8,151 | 4,523 | 7,160 | 6,384 | Upgrade |
Current Income Taxes Payable | 223.05 | 166.17 | 293.86 | 603.25 | 1,031 | 262.9 | Upgrade |
Other Current Liabilities | 4,850 | 9,725 | 6,861 | 6,988 | 6,408 | 8,865 | Upgrade |
Total Current Liabilities | 52,593 | 44,744 | 45,268 | 43,737 | 37,438 | 50,011 | Upgrade |
Other Long-Term Liabilities | 2,194 | 2,294 | 2,035 | 2,091 | 2,282 | 2,379 | Upgrade |
Total Liabilities | 54,788 | 47,038 | 47,302 | 45,828 | 39,720 | 52,389 | Upgrade |
Common Stock | 60,000 | 60,000 | 60,000 | 60,000 | 60,000 | 60,000 | Upgrade |
Retained Earnings | 25,972 | 26,296 | 29,365 | 32,416 | 31,444 | 36,288 | Upgrade |
Comprehensive Income & Other | 3,252 | 3,252 | 3,252 | 3,252 | 3,252 | 3,252 | Upgrade |
Shareholders' Equity | 89,224 | 89,549 | 92,617 | 95,669 | 94,697 | 99,541 | Upgrade |
Total Liabilities & Equity | 144,012 | 136,587 | 139,920 | 141,496 | 134,416 | 151,930 | Upgrade |
Net Cash (Debt) | 69,695 | 70,688 | 115,593 | 121,608 | 115,000 | 120,088 | Upgrade |
Net Cash Growth | -39.71% | -38.85% | -4.95% | 5.75% | -4.24% | -7.30% | Upgrade |
Net Cash Per Share | 11615.82 | 11781.37 | 19265.48 | 20270.66 | 19153.23 | 20008.64 | Upgrade |
Filing Date Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6.02 | Upgrade |
Total Common Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6.02 | Upgrade |
Working Capital | 88,880 | 89,108 | 91,526 | 95,976 | 94,808 | 99,332 | Upgrade |
Book Value Per Share | 14870.72 | 14924.76 | 15436.21 | 15941.10 | 15786.48 | 16527.07 | Upgrade |
Tangible Book Value | 89,224 | 89,549 | 92,617 | 95,669 | 94,697 | 99,541 | Upgrade |
Tangible Book Value Per Share | 14870.72 | 14924.76 | 15436.21 | 15941.10 | 15786.48 | 16527.07 | Upgrade |
Buildings | 15,499 | - | - | - | - | - | Upgrade |
Machinery | 3,797 | 3,797 | 3,797 | - | - | - | Upgrade |
Construction In Progress | 1,082 | 1,082 | 1,082 | 1,082 | 1,082 | 1,082 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.